ARS Pharmaceuticals (NasdaqGM:SPRY) Q3 2025 Earnings Call November 10, 2025 08:30 AM ET Speaker5Good morning and welcome to ARS Pharmaceuticals conference call. At this time, all participants are in a listen-only mode. After the company's prepared remarks, we will open the line for questions. Please be advised that today's conference is being recorded. I'll now turn the call over to Justin Chakma, Chief Business Officer. Please go ahead.Speaker2Good morning and thank you for joining our third quarter 2025 e ...